EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma

Faye Lewis, James Beirne, Brian Henderson, Lucy Norris, Karen Cadoo, Tanya Kelly, Cara Martin, Sinéad Hurley, Marika Kanjuga, Lorraine O'Driscoll, Kathy Gately, Ezgi Oner und 11 weitere

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217279 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2024. Verfasst von Faye Lewis und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histopathology, School of Medicine, Trinity College Dublin, Dublin, Ireland; Department of Obstetrics and Gynaecology, School of Medici…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Higher Education Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial ovarian carcinoma (EOC) is the eighth most common cancer in women and the leading cause of gynaecological cancer death, predominantly due to the absence of effective screening tools, advanced stage at diagnosis, and high rates of recurrence. Circulating tumour cells (CTCs), a rare subset of tumour cells that disseminate from a tumour and migrate into the circulation, play a pivotal role in the metastatic cascade, and therefore hold promise as biomarkers for disease monitoring and prognostication. Exploring CTCs from liquid biopsies is an appealing approach for research and clinical practice, given it is minimally invasive, facilitates serial sampling and enables the capture of the entire spectrum of cancer cells circulating in the blood. The prognostic utility of CTC enumeration has been FDA-approved for clinical use in metastatic breast, prostate, and colorectal cancers. However, the unique biology of EOC, discussed herein, compounds the detection and characterisation complexities already inherent in CTC research, consequently hindering progress towards clinical applications. The aim of this review is to provide an overview of both the biological and clinical challenges encountered in harnessing the power of CTCs in EOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingCarcinoma, Ovarian EpithelialOvarian NeoplasmsBiomarkers, TumorHumansFemalePrognosisLiquid Biopsy

Stichwörter der Autor:innen

BiomarkersCirculating tumour cells (CTCs)Epithelial ovarian carcinoma (EOC)Liquid biopsy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Histopathology, School of Medicine, Trinity College Dublin, Dublin, Ireland; Department of Obstetrics and Gynaecology, School of Medicine, Trinity College Dublin, Dublin, Ireland; Trinity St. James's Cance…
  • Blackrock Health Hermitage Clinic, Old Lucan Road, Dublin, Ireland.
  • Department of Obstetrics and Gynaecology, School of Medicine, Trinity College Dublin, Dublin, Ireland; Trinity St. James's Cancer Institute, Trinity College Dublin, Dublin, Ireland.
  • Trinity St. James's Cancer Institute, Trinity College Dublin, Dublin, Ireland; The Haematology, Oncology and Palliative Care (HOPe) Directorate, St James's Hospital, Dublin, Ireland.
  • Department of Histopathology, School of Medicine, Trinity College Dublin, Dublin, Ireland; Trinity St. James's Cancer Institute, Trinity College Dublin, Dublin, Ireland.
  • Department of Histopathology, School of Medicine, Trinity College Dublin, Dublin, Ireland; Trinity St. James's Cancer Institute, Trinity College Dublin, Dublin, Ireland; Department of Clinical Medicine, School of Medici…

Förderung

  • Higher Education Authority

Zitieren

APA

Lewis, F., Beirne, J., Henderson, B., Norris, L., Cadoo, K., Kelly, T., Martin, C., Hurley, S., Kanjuga, M., O'Driscoll, L., Gately, K., Oner, E., Saini, V. M., Brooks, D., Selemidis, S., Kamran, W., Haughey, N., Maguire, P., O'Gorman, C., …, & O'Toole, S. A. (2024). Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217279

Vancouver

Lewis F, Beirne J, Henderson B, Norris L, Cadoo K, Kelly T, et al. Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217279

BibTeX
@article{Lewis2024,
  author = {Lewis, Faye and Beirne, James and Henderson, Brian and Norris, Lucy and Cadoo, Karen and Kelly, Tanya and Martin, Cara and Hurley, Sinéad and Kanjuga, Marika and O'Driscoll, Lorraine and Gately, Kathy and Oner, Ezgi and Saini, Volga M and Brooks, Doug and Selemidis, Stavros and Kamran, Waseem and Haughey, Niamh and Maguire, Patrick and O'Gorman, Catherine and Saadeh, Feras Abu and Ward, Mark P and O'Leary, John J and O'Toole, Sharon A},
  title = {Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217279}
}
Kostenlos starten →